Zhaoyan's new drug is on the market
Zhaoyan New Drug was listed on the Shanghai stock exchange in 2017. At 9:30 a.m. on February 26,2021, it was successfully listed on the main board of the Hong Kong stock exchange.
Zhaoyan's New Drug Launch Time
Zhao Yan New Drug was listed on the main board of the A-share Shanghai Exchange on August 25th, 2017, and listed on Hong Kong stocks on February 26th, 2021.
Zhaoyan New Drug bought on March 14
Zhao Yan New Drug was bought by foreign capital, the main capital, and the sales department on March 14th. Specifically, foreign investors bought 23,900 shares, the main capital bought 81,934,400 yuan, and the sales department seats bought 62,716,800 yuan. These data showed that Zhao Yan's new drug had received the attention and purchase of many funds on that date.
Zhaoyan New Drug 2024 Target Price
The target price of Zhaoyan New Drug in 2024 was about 19.6 yuan (Guotai Junan released a research report on November 3). In the past month, Zhaoyan New Drug had received the attention of two research reports from stockholders, with an average target price of 21.30 yuan.
Zhaoyan New Medicine
Zhao Yan New Drug was a company that provided preclinic research services and sold experimental animals. The actual controllers of the company were Feng Yuxia and Zhou Zhiwen, who held 34% of the company's shares. However, the actual controllers of the company had recently received a warning letter from the Beijing stock exchange bureau because they did not disclose relevant information on time when they reduced their shares. In addition, Zhao Yan's new drug had a strong technical advantage in the field of non-clinical safety evaluation of drugs. It had also stabilized its core technology during the industry's low point and achieved high-quality sustainable development. Although the company encountered some difficulties in 2023, it still maintained stable business development.
New drug hn0037
HN0037 was a Class 1 new drug project of Huinuo Biomedicine Technology (Hangzhou) Co., Ltd. It was approved for clinical trials by the State Drug Administration (NMPA) on August 19th, 2021. It was currently the only highly selective hsv-helicase-primase inhibition drug in China. Its mechanism of action was to prevent the virus from being synthesized from scratch by suppressing the Herpesvirus helicase-primase complex, and it did not need to be activated by the viral thymidine Kinase in the cells infected with Herpesvirus. It also had a protective effect on uninfected cells. Its half-life was as long as 80 hours, and it could be taken once a day, effectively improving the patient's compliance with medication. The novel "Shou Zang" is equally exciting. Everyone is welcome to click and read it!
Zhao Yan's New Drug News
On November 5, the data of Shanghai and Shanghai Finance showed that Zhaoyan New Drug had obtained 60 million yuan of financing purchase, ranking 406th in the two cities. The repayment amount of the day's financing was 41 million yuan, and the net purchase was 18.6629 million yuan. In the last three trading days (1st-5th), Zhao Yan New Drug was bought with 18 million yuan, 6 million yuan and 60 million yuan respectively. In terms of margin lending, 2,100 shares were sold on the same day, and 20,400 shares were bought. As of November 5, Southbound Capital held 41.1067 million shares of Zhaoyan New Drug, with a market value of 400 million Hong Kong dollars, a decrease of 3.5965 million Hong Kong dollars compared with the previous trading day, and the number of shares held accounted for 34.53% of the issued shares. As of the close on the 5th, Zhao Yan New Drug fell 0.51% on the day, closing at 9.72 Hong Kong dollars.
The Meaning of Zhaoyan's Name
The name Zhao Yan meant bright and obvious. The basic meaning of the word Zhao was bright and bright, but it could also be extended to obvious and remarkable. Parents gave this name to their children because they hoped that their children would become bright and outstanding people. According to the explanations of documents [1],[3],[4],[7],[9], and [10], the word Zhao could also mean incomparable glory, brilliance, grace, hope, and a bright future. Therefore, the meaning of the name Zhao Yan could be understood as a hope for the child to be bright, obvious, and full of hope.
Luo Zhaoyan's weapon
Luo Zhaoyan's weapon was called " Blade Brilliance ", and it was more elegant than a broadsword. In the game, Luo Zhaoyan had used this sword in battle. Blade Glory was a suitable name, especially for female characters. As for how to obtain Luo Zhaoyan's other weapons, the search results did not mention any specific information.
Luo Zhaoyan's analysis
Luo Zhaoyan and Xianqing were two characters in the Legend of the Sword and Fairy 6. Xian Qing was a thousand-year-old wolf demon. He selflessly and generously lent his cultivation to others. Luo Zhaoyan was a girl. She had half of the cultivation of an idle official, but she could not live forever. At first, Xianqing followed Luo Zhaoyan and his group because he was curious about her identity, but later, he stayed behind for Luo Zhaoyan. He had protected Luo Zhaoyan during the murder of the Luo family and helped her find a way to resolve the effects of her bloodline. Regarding the development of Luo Zhaoyan and Xianqing's relationship, some people believed that Xianqing was initially curious about Luo Zhaoyan, but later developed true feelings for her. However, the information given did not provide a detailed analysis of Luo Zhaoyan and Xianqing.
Luo Zhaoyan's Ending
Luo Zhaoyan's ending was to be together with Xianqing, to search for the method of immortality together. In "Praying for the Present," Yue Jin died and Yue Qi was forgotten. Luo Zhaoyan and Xian Qing knew each other, but they did not know Shuangyue. Mingxiu was surprised by the new Jin Chao but didn't recognize him. Luo Zhaoyan and Xianqing used their own ways to interpret the true meaning of love.